期刊
TOXICOLOGICAL SCIENCES
卷 131, 期 2, 页码 375-386出版社
OXFORD UNIV PRESS
DOI: 10.1093/toxsci/kfs303
关键词
nongenotoxic carcinogenesis; phenobarbital; biomarker; noncoding RNAs; Dlk1-Dio3 imprinted cluster; epigenetics
类别
资金
- Innovative Medicine Initiative Joint Undertaking (IMI JU) [115001]
- Novartis
- NIBR
- IMI-MARCAR
- MRC [MC_PC_U127574433, MC_U127574433] Funding Source: UKRI
- Cancer Research UK [10822] Funding Source: researchfish
- Medical Research Council [MC_U127574433, MC_PC_U127574433] Funding Source: researchfish
The molecular events during nongenotoxic carcinogenesis and their temporal order are poorly understood but thought to include long-lasting perturbations of gene expression. Here, we have investigated the temporal sequence of molecular and pathological perturbations at early stages of phenobarbital (PB) mediated liver tumor promotion in vivo. Molecular profiling (mRNA, microRNA [miRNA], DNA methylation, and proteins) of mouse liver during 13 weeks of PB treatment revealed progressive increases in hepatic expression of long noncoding RNAs and miRNAs originating from the Dlk1-Dio3 imprinted gene cluster, a locus that has recently been associated with stem cell pluripotency in mice and various neoplasms in humans. PB induction of the Dlk1-Dio3 cluster noncoding RNA (ncRNA) Meg3 was localized to glutamine synthetase-positive hypertrophic perivenous hepatocytes, sug- gesting a role for -catenin signaling in the dysregulation of Dlk1-Dio3 ncRNAs. The carcinogenic relevance of Dlk1-Dio3 locus ncRNA induction was further supported by in vivo genetic dependence on constitutive androstane receptor and -catenin pathways. Our data identify Dlk1-Dio3 ncRNAs as novel candidate early biomarkers for mouse liver tumor promotion and provide new opportunities for assessing the carcinogenic potential of novel compounds.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据